These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18541364)
1. The Fbxw7/hCdc4 tumor suppressor in human cancer. Tan Y; Sangfelt O; Spruck C Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364 [TBL] [Abstract][Full Text] [Related]
2. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001 [TBL] [Abstract][Full Text] [Related]
3. Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch. Ishikawa Y; Hosogane M; Okuyama R; Aoyama S; Onoyama I; Nakayama KI; Nakayama K Oncogene; 2013 Apr; 32(15):1921-32. PubMed ID: 22665065 [TBL] [Abstract][Full Text] [Related]
4. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis. Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516 [TBL] [Abstract][Full Text] [Related]
5. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106 [TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897 [TBL] [Abstract][Full Text] [Related]
9. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418 [TBL] [Abstract][Full Text] [Related]
10. Recent insight into the role of FBXW7 as a tumor suppressor. Yumimoto K; Nakayama KI Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998 [TBL] [Abstract][Full Text] [Related]
11. FBXW7 and DNA copy number instability. Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203 [TBL] [Abstract][Full Text] [Related]
12. The FBXW7 beta-form is suppressed in human glioma cells. Gu Z; Inomata K; Ishizawa K; Horii A Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947 [TBL] [Abstract][Full Text] [Related]
13. hCDC4 gene mutations in endometrial cancer. Spruck CH; Strohmaier H; Sangfelt O; Müller HM; Hubalek M; Müller-Holzner E; Marth C; Widschwendter M; Reed SI Cancer Res; 2002 Aug; 62(16):4535-9. PubMed ID: 12183400 [TBL] [Abstract][Full Text] [Related]
14. The Role of FBXW7 in Gynecologic Malignancies. Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J Cells; 2023 May; 12(10):. PubMed ID: 37408248 [TBL] [Abstract][Full Text] [Related]
15. Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. Kwak EL; Moberg KH; Wahrer DC; Quinn JE; Gilmore PM; Graham CA; Hariharan IK; Harkin DP; Haber DA; Bell DW Gynecol Oncol; 2005 Jul; 98(1):124-8. PubMed ID: 15913747 [TBL] [Abstract][Full Text] [Related]
16. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis. Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. Li J; Guo Y; Liang X; Sun M; Wang G; De W; Wu W J Cancer Res Clin Oncol; 2012 May; 138(5):763-74. PubMed ID: 22270966 [TBL] [Abstract][Full Text] [Related]
18. Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis. Cao J; Ge MH; Ling ZQ Medicine (Baltimore); 2016 Feb; 95(7):e2496. PubMed ID: 26886596 [TBL] [Abstract][Full Text] [Related]
19. Aberrant regulation of FBW7 in cancer. Wang L; Ye X; Liu Y; Wei W; Wang Z Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581 [TBL] [Abstract][Full Text] [Related]
20. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]